Savara, Inc. (SVRA)
5.59
+0.03
(+0.54%)
USD |
NASDAQ |
Aug 25, 16:00
5.59
0.00 (0.00%)
After-Hours: 19:07
Savara Total Return Level : 5.56 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 5.56 |
| August 21, 2026 | 5.59 |
| August 20, 2026 | 5.49 |
| August 19, 2026 | 5.58 |
| August 18, 2026 | 5.37 |
| August 17, 2026 | 5.37 |
| August 14, 2026 | 5.38 |
| August 13, 2026 | 5.27 |
| August 12, 2026 | 5.70 |
| August 11, 2026 | 5.57 |
| August 10, 2026 | 5.73 |
| August 07, 2026 | 5.83 |
| August 06, 2026 | 5.79 |
| August 05, 2026 | 5.51 |
| August 04, 2026 | 5.41 |
| August 03, 2026 | 5.33 |
| July 31, 2026 | 5.46 |
| July 30, 2026 | 5.54 |
| July 29, 2026 | 5.28 |
| July 28, 2026 | 5.33 |
| July 27, 2026 | 5.43 |
| July 24, 2026 | 5.51 |
| July 23, 2026 | 5.75 |
| July 22, 2026 | 5.65 |
| July 21, 2026 | 5.84 |
| Date | Value |
|---|---|
| July 20, 2026 | 5.49 |
| July 17, 2026 | 5.52 |
| July 16, 2026 | 5.52 |
| July 15, 2026 | 5.81 |
| July 14, 2026 | 5.69 |
| July 13, 2026 | 5.74 |
| July 10, 2026 | 6.03 |
| July 09, 2026 | 6.29 |
| July 08, 2026 | 6.38 |
| July 07, 2026 | 6.21 |
| July 06, 2026 | 6.20 |
| July 02, 2026 | 6.22 |
| July 01, 2026 | 6.06 |
| June 30, 2026 | 6.16 |
| June 29, 2026 | 6.03 |
| June 26, 2026 | 5.90 |
| June 25, 2026 | 6.03 |
| June 24, 2026 | 5.83 |
| June 23, 2026 | 5.78 |
| June 22, 2026 | 5.69 |
| June 18, 2026 | 5.50 |
| June 17, 2026 | 5.38 |
| June 16, 2026 | 5.30 |
| June 15, 2026 | 5.33 |
| June 12, 2026 | 5.26 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Gilead Sciences, Inc. | 213.86 |
| Insmed, Inc. | 123.98 |
| United Therapeutics Corp. | 512.88 |
| Vertex Pharmaceuticals, Inc. | 547.59 |
| SELLAS Life Sciences Group, Inc. | 14.32 |